-
2
-
-
0342708781
-
Annual prescription survey
-
Glaser M. Annual prescription survey. Drug Topics 1995;139:43-8.
-
(1995)
Drug Topics
, vol.139
, pp. 43-48
-
-
Glaser, M.1
-
4
-
-
0023214286
-
Influence of tablet dissolution on furosemide bioavailability: A bioequivalence study
-
McNamara PJ, Foster TS, Digenis GA, et al. Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study. Pharm Res 1987;4:150-3.
-
(1987)
Pharm Res
, vol.4
, pp. 150-153
-
-
McNamara, P.J.1
Foster, T.S.2
Digenis, G.A.3
-
6
-
-
0021714621
-
Implications of intraindividual variability in bioavailability studies of furosemide
-
Grahnén A, Hammarlund M, Lundqvist T. Implications of intraindividual variability in bioavailability studies of furosemide. Eur J Pharmacol 1984;27:595-602.
-
(1984)
Eur J Pharmacol
, vol.27
, pp. 595-602
-
-
Grahnén, A.1
Hammarlund, M.2
Lundqvist, T.3
-
7
-
-
0024547591
-
Furosemide pharmacokinetics and pharmacodynamics in health and disease - an update
-
Hammarlund-Udenaes M, Benet LZ. Furosemide pharmacokinetics and pharmacodynamics in health and disease - an update. J Pharmacokinet Biopharm 1989;17:1-46.
-
(1989)
J Pharmacokinet Biopharm
, vol.17
, pp. 1-46
-
-
Hammarlund-Udenaes, M.1
Benet, L.Z.2
-
8
-
-
26744477502
-
Estimating the bioequivalence of furosemide products using a population approach
-
Sambol NC, Dettelbach HR, Cerda JJ, et al. Estimating the bioequivalence of furosemide products using a population approach [abstr]. Eur J Clin Pharmacol 1989;36:A231.
-
(1989)
Eur J Clin Pharmacol
, vol.36
-
-
Sambol, N.C.1
Dettelbach, H.R.2
Cerda, J.J.3
-
9
-
-
0002617371
-
Analysis of bioequivalence of three generic furosemide products to brand name product using a population approach
-
Gatti G, Brater C, Murray M, Sambol N. Analysis of bioequivalence of three generic furosemide products to brand name product using a population approach [abstr]. Clin Pharmacol Ther 1994;55:195.
-
(1994)
Clin Pharmacol Ther
, vol.55
, pp. 195
-
-
Gatti, G.1
Brater, C.2
Murray, M.3
Sambol, N.4
-
10
-
-
0029133024
-
Analysis of a bioequivalence trial using mixed effects modeling
-
Sambol NC. Analysis of a bioequivalence trial using mixed effects modeling. Drug Information J 1995;29:841-5.
-
(1995)
Drug Information J
, vol.29
, pp. 841-845
-
-
Sambol, N.C.1
-
12
-
-
0028849517
-
Effects of NSAIDs on glomerular filtration fate in elderly patients without and with renal insufficiency
-
Murray MD, Greene PK, Kuzmik DD, et al. Effects of NSAIDs on glomerular filtration fate in elderly patients without and with renal insufficiency. AmJ Med Sci 1995;310:188-97.
-
(1995)
Am J Med Sci
, vol.310
, pp. 188-197
-
-
Murray, M.D.1
Greene, P.K.2
Kuzmik, D.D.3
-
13
-
-
0016916438
-
Prediction of creatinine clearance from serum creatinine
-
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
-
(1976)
Nephron
, vol.16
, pp. 31-41
-
-
Cockcroft, D.W.1
Gault, M.H.2
-
16
-
-
0019969409
-
The time course of delivery of furosemide into urine: An independent determinant of overall response
-
Kaojaren S, Day B, Brater C. The time course of delivery of furosemide into urine: an independent determinant of overall response. Kidney Int 1982;22:69-74.
-
(1982)
Kidney Int
, vol.22
, pp. 69-74
-
-
Kaojaren, S.1
Day, B.2
Brater, C.3
-
17
-
-
0018948662
-
Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay
-
Smith DE, Lin ET, Benet LZ. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metab Dispos 1980;8:337-42.
-
(1980)
Drug Metab Dispos
, vol.8
, pp. 337-342
-
-
Smith, D.E.1
Lin, E.T.2
Benet, L.Z.3
-
18
-
-
0019952632
-
Disposition and absolute bioavailability of furosemide in healthy males
-
Waller ES, Hamilton SF, Massarella JW, et al. Disposition and absolute bioavailability of furosemide in healthy males. J Pharm Sci 1982;71:1105-8.
-
(1982)
J Pharm Sci
, vol.71
, pp. 1105-1108
-
-
Waller, E.S.1
Hamilton, S.F.2
Massarella, J.W.3
-
19
-
-
0020583238
-
Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers
-
Ogata H, Zugarni, Ejima A, Kawatsu Y. Bioavailability of two preparations of furosemide and their pharmacological activity in normal volunteers. Eur J Clin Pharmacol 1983;24:791-6.
-
(1983)
Eur J Clin Pharmacol
, vol.24
, pp. 791-796
-
-
Ogata, H.1
Zugarni2
Ejima, A.3
Kawatsu, Y.4
-
20
-
-
0019785890
-
Understanding of the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models
-
Holford NHG, Sheiner LB. Understanding of the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981;6:429-52.
-
(1981)
Clin Pharmacokinet
, vol.6
, pp. 429-452
-
-
Holford, N.H.G.1
Sheiner, L.B.2
-
23
-
-
0021969464
-
Furosemide absorption altered in decompensated congestive heart failure
-
Vasko MR, Brown-Cartwright D, Knochel JP, Nixon JV, Brater DC. Furosemide absorption altered in decompensated congestive heart failure. Ann Intern Med 1985;102:314-18.
-
(1985)
Ann Intern Med
, vol.102
, pp. 314-318
-
-
Vasko, M.R.1
Brown-Cartwright, D.2
Knochel, J.P.3
Nixon, J.V.4
Brater, D.C.5
-
24
-
-
0022001003
-
Resistance to diuretics: Why it happens and what to do about it
-
Brater DC. Resistance to diuretics: why it happens and what to do about it. Drugs 1985;30:427-43.
-
(1985)
Drugs
, vol.30
, pp. 427-443
-
-
Brater, D.C.1
-
26
-
-
0000709558
-
Power of the multivariate analysis of variance tests
-
Stevens JP. Power of the multivariate analysis of variance tests. Psychol Bull 1980;88:728-37.
-
(1980)
Psychol Bull
, vol.88
, pp. 728-737
-
-
Stevens, J.P.1
|